Human Genome Sciences obtains United States patent.
Human Genome Sciences, Inc. (Rockville, MD) and University of Michigan (Ann Arbor, MI) has patented Death Domain Containing Receptor (DR3 and DR3-V1) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity. (US 6,951,735)
|Printer friendly Cite/link Email Feedback|
|Publication:||BIOTECH Patent News|
|Date:||Oct 1, 2005|
|Previous Article:||Bayer Pharmaceuticals obtains United States patent.|
|Next Article:||Gen-Probe receives FDA approval for West Nile Virus blood screening assay.|